VistaGen Therapeutics, Inc.VTGNNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
244.00%
↑ 761% above average
Average (39q)
28.35%
Historical baseline
Range
High:697.17%
Low:-387.81%
Volatility
3827.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 244.00% |
| Q2 2025 | 600.00% |
| Q1 2025 | -106.41% |
| Q4 2024 | 27.87% |
| Q3 2024 | 117.86% |
| Q2 2024 | -57.43% |
| Q1 2024 | -52.04% |
| Q4 2023 | 47.99% |
| Q3 2023 | 57.06% |
| Q2 2023 | 0.80% |
| Q1 2023 | -2.23% |
| Q4 2022 | 120.12% |
| Q3 2022 | -387.81% |
| Q2 2022 | 697.17% |
| Q1 2022 | -89.13% |
| Q4 2021 | -0.03% |
| Q3 2021 | 1.10% |
| Q2 2021 | -19.87% |
| Q1 2021 | 40.91% |
| Q4 2020 | -6.11% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | -100.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |